SHMLF (SHL Telemedicine) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHMLF SHL Telemedicine Ltd SHMLF
52 GF Score
Price $4.84
GF Value $12.26
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine 3-Month Share Buyback Ratio?

SHL Telemedicine SHMLF 52 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates SHMLF with a GF Score™ of 52/100 and a GF Value™ of $12.26. The stock has 3 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

SHMLF
52GF Score
SHL Telemedicine Ltd SHMLF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
SHL Telemedicine (SHMLF) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for SHL Telemedicine and its competitors.
Is SHL Telemedicine's 3-Month Share Buyback Ratio too high?
SHL Telemedicine's current 3-Month Share Buyback Ratio is 0.00. Overall, SHL Telemedicine has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's 3-Month Share Buyback Ratio compare to VEEV and BTSG?
SHL Telemedicine's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Month Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for SHL Telemedicine and its competitors. SHL Telemedicine's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is $12.26, compared to a current price of $4.84 — trading 60.5% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (SHMLF) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of $4.84 is trading 60.5% below its estimated GF Value™ of $12.26.

Key valuation signals for SHMLF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $12.26 vs. price of $4.84 (60.5% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges 0QMX:UKSHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score

Get the complete analysis for SHMLF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price
$12.26
GF Value